Evidence map›Paper›PMID 40430073›Full record

ArticleInternational journal of molecular sciences2025

Multiplatform Metabolomic Profiling of the Unilateral Ureteral Obstruction Murine Model of CKD.

Paula Cuevas-Delgado, Verónica Miguel, Santiago Lamas, Coral Barbas, Francisco J Rupérez

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Paula Cuevas-DelgadoCentre for Metabolomics and Bioanalysis (CEMBIO), School of Pharmacy, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Boadilla del Monte, Madrid 28660, Spain.ORCID 0000-0002-8726-760X
Verónica MiguelProgram of Physiological and Pathological Processes, Centro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), c. Nicolás Cabrera 1, Madrid 28049, Spain.ORCID 0000-0001-9863-0710
Santiago LamasProgram of Physiological and Pathological Processes, Centro de Biología Molecular "Severo Ochoa" (CBMSO, CSIC-UAM), c. Nicolás Cabrera 1, Madrid 28049, Spain.ORCID 0000-0001-5166-4155
Coral BarbasCentre for Metabolomics and Bioanalysis (CEMBIO), School of Pharmacy, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Boadilla del Monte, Madrid 28660, Spain.ORCID 0000-0003-4722-491X
Francisco J RupérezCentre for Metabolomics and Bioanalysis (CEMBIO), School of Pharmacy, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Boadilla del Monte, Madrid 28660, Spain.ORCID 0000-0001-6457-6234

Funding

Comunidad Autónoma de Madrid INNOREN-CM S2022/BMD-7221Comunidad Autónoma de Madrid NOVELREN-CM B2017/BMD3751MINECO BES-793 2013-065986Ministerio de Ciencia, Innovación y Universidades PID2019-104233RB-100/AEI/10.13039/501100011033Ministerio de Ciencia, Innovación y Universidades PID2021-122490NB-I00/AEI/10.13039/501100011033 by ERDF-"A way of making Europe"
6 · The paper itself

Abstract

In chronic kidney disease (CKD) research, animal models such as the unilateral ureteral obstruction (UUO) rodent model are crucial to understanding disease progression, particularly renal fibrosis. Despite its widespread use, the molecular mechanisms driving CKD remain incompletely understood. Given the interplay between metabolism and fibrosis, a comprehensive metabolomic analysis of UUO renal tissue is necessary. This study involved untargeted multiplatform analysis using liquid chromatography (LC), gas chromatography (GC), and capillary electrophoresis (CE) coupled with mass spectrometry (MS) to examine murine kidney tissue from the UUO model. The results highlight metabolic changes associated with tubulointerstitial fibrosis, which affect pathways such as the tricarboxylic acid (TCA) cycle, the urea cycle, and lipid metabolism. In particular, fibrosis impacts the lipidomic profile, with decreases in most lipid classes and increases in specific glycerophospholipids, hexosylceramides, and cholesterol esters. These findings demonstrate the value of a multiplatform approach in elucidating metabolic alterations in CKD, providing information on the underlying molecular mechanisms and paving the way for further research.

Indexed as

MetabolomeMetabolomicsRenal Insufficiency, ChronicUreteral ObstructionAnimalsChromatography, LiquidDisease Models, AnimalElectrophoresis, CapillaryFibrosisKidneyLipid MetabolismMaleMiceMice, Inbred C57BLCE-MSGC-MSkidney tissueLC-MSrenal fibrosisuntargeted metabolomicsUUO

Identifiers

PMID40430073
PMCPMC12112560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.